Derma Sciences Inc (DSCI)

7.03
0.03 0.36
NASDAQ : Health Care
Prev Close 7.00
Open 7.00
Day Low/High 6.97 / 7.05
52 Wk Low/High 2.85 / 7.35
Volume 15.99K
Avg Volume 462.00K
Exchange NASDAQ
Shares Outstanding 28.27M
Market Cap 197.88M
EPS -1.50
P/E Ratio 5.56
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Derma...

DERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Derma Sciences, Inc. (DSCI) Over The Proposed Sale Of The Company To Integra LifeSciences Holdings Corporation

DERMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Derma Sciences, Inc. (DSCI) Over The Proposed Sale Of The Company To Integra LifeSciences Holdings Corporation

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Derma Sciences, Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Derma...

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Into Whether The Sale Of Derma Sciences, Inc. To Integra LifeSciences Holdings Corporation For $7 Per Share Is Fair To Shareholders

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Into Whether The Sale Of Derma Sciences, Inc. To Integra LifeSciences Holdings Corporation For $7 Per Share Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Derma Sciences, Inc.

DERMA SCIENCES, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By Integra LifeSciences Holdings Corporation May Be Unfair To Shareholders

DERMA SCIENCES, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By Integra LifeSciences Holdings Corporation May Be Unfair To Shareholders

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Derma Sciences, Inc.

Derma Sciences Buys MEDIHONEY® Brand From Long-Term Partner

Derma Sciences Buys MEDIHONEY® Brand From Long-Term Partner

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that it has purchased the MEDIHONEY® brand and related intellectual property and goodwill from...

Derma Sciences Soars Almost 40% on Buyout by Integra

Derma Sciences Soars Almost 40% on Buyout by Integra

The company's shares hit $6.95 Wednesday midday.

Derma Sciences To Be Acquired By Integra LifeSciences For $7.00 Per Share Of Common Stock In Cash

Derma Sciences To Be Acquired By Integra LifeSciences For $7.00 Per Share Of Common Stock In Cash

Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that it has signed a definitive agreement whereby Derma Sciences will be acquired by Integra...

Derma Sciences To Present At The Canaccord Genuity Medical Technologies & Diagnostics Forum

Derma Sciences To Present At The Canaccord Genuity Medical Technologies & Diagnostics Forum

Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that Stephen T.

Derma Sciences Reports 2016 Third Quarter Financial Results

Derma Sciences Reports 2016 Third Quarter Financial Results

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and nine months ended September 30, 2016.

Derma Sciences To Hold Third Quarter Financial Results Conference Call On November 10th

Derma Sciences To Hold Third Quarter Financial Results Conference Call On November 10th

Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that it will hold a conference call on November 10, 2016 to discuss the financial results for the...

Derma Sciences To Present At The Ladenburg Thalmann 2016 Healthcare Conference

Derma Sciences To Present At The Ladenburg Thalmann 2016 Healthcare Conference

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that Stephen T.

Derma Sciences Completes The Sale Of Its First Aid Products Division

Derma Sciences Completes The Sale Of Its First Aid Products Division

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the completion of the sale of its First Aid Division (FAD) to Dukal Corporation for $12.

Derma Sciences Receives Reimbursement Coding For New MEDIHONEY® Hydrogel Dressings

Derma Sciences Receives Reimbursement Coding For New MEDIHONEY® Hydrogel Dressings

Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the launch of new, MEDIHONEY ® Hydrogel Sheet Dressings and the receipt of Healthcare Common...

Derma Sciences' AMNIOEXCEL® Now Eligible For Reimbursement By Medicare Administrative Contractor NGS

Derma Sciences' AMNIOEXCEL® Now Eligible For Reimbursement By Medicare Administrative Contractor NGS

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces that National Government Services (NGS), a Medicare Administrative Contractor (MAC) for Part B serving...

Derma Sciences Names Russell Olsen President Of Advanced Wound Care

Derma Sciences Names Russell Olsen President Of Advanced Wound Care

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the appointment of Russell Olsen as President of Advanced Wound Care.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABEV, ACM, ACTS, BID, CC, COH, COKE, DSCI, EGRX, FNV, NWS, SHO, SSNC Downgrades: AMBC, HHC, HLF, LXFR, ROG, TCP Initiations: APLE, CNXR, EKSO, GNL, HLTH, LIND Read on to get TheStreet Quant Ratings' detailed report:

Derma Sciences Reports 2016 Second Quarter Financial Results

Derma Sciences Reports 2016 Second Quarter Financial Results

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and six months ended June 30, 2016.

Derma Sciences To Hold Second Quarter Financial Results Conference Call On August 9th

Derma Sciences To Hold Second Quarter Financial Results Conference Call On August 9th

Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that it will hold a conference call on August 9, 2016 to discuss the financial results for the...

Derma Sciences To Acquire BioD, Solidify Its Leadership Position In Advanced Wound Care And Regenerative Products

Derma Sciences To Acquire BioD, Solidify Its Leadership Position In Advanced Wound Care And Regenerative Products

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the signing of a definitive agreement to acquire BioD, LLC for an immediate transaction value of $21.

Derma Sciences To Sell First Aid Products Division For Approximately $12.2 Million

Derma Sciences To Sell First Aid Products Division For Approximately $12.2 Million

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the signing of a definitive agreement to sell its First Aid Division (FAD) to Dukal Corporation for...

Derma Sciences Reports 2016 First Quarter Financial Results

Derma Sciences Reports 2016 First Quarter Financial Results

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three months ended March 31, 2016.

Derma Sciences To Hold First Quarter Financial Results Conference Call On May 11th

Derma Sciences To Hold First Quarter Financial Results Conference Call On May 11th

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that it will hold a conference call on May 11, 2016 to discuss the financial results for the first...